Flor, Dianelyn B.
HRN: 16-61-55 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/08/2025
CEFUROXIME 500MG (TAB)
10/08/2025
10/15/2025
PO
500 MG/TAB
BID
S/P EXLAP
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes